ARTHRITIS DRUGS ADVISORY COMMITTEE
August 17, 2001
Briefing Information
Safety Updates
Safety Update on TNF-a Antagonists: Infliximab and
Etanercept
First edition superceded by addendum below pdf
Mohan, Niveditha, Evelyn T Edwards, Thomas R Cupps, Patrick J Oliverio, Glenn Sandberg, Heidi Crayton, John R Richert, Jeffrey N Siege, "Demyelination occurring during anti-TNFa therapy for inflammatory arthritides." Manuscript*
Tables pdf xls superceded by revised version pdf xls
EnbrelŪ (etanercept), Immunex Corporation and Wyeth-Ayerst Laboratories pdf
Remicade, Centocor pdf
*May be viewed at: Dockets Management Branch, Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, Maryland 20852, between the hours of 9 a.m. to 4:00 p.m. est, Monday through Friday, except for federal holidays.